Disparate biomechanical properties of the aorta in non-aneurysmal and aneurysmal mice treated with angiotensin II.
Ontology highlight
ABSTRACT: In vivo angiotensin II (AngII)-treatment is a widely used experimental model to induce cardiovascular disease and results in a high likelihood of abdominal aorta aneurysm (AAA) formation. This involves progressive and irreversible focal dilation of the abdominal aorta and induces adverse aortic connective tissue remodeling contributing to aortic wall stiffening through inflammation, elastin degradation, and collagen restructuring. Hence, the present study aimed to investigate how AAA formation in AngII-treated mice affects aortic function and biomechanics. To this end, C57Bl/6J mice were treated with AngII (1000 ng/[kg.min]) or PBS infusion for 28 days. Peripheral blood pressure, echocardiography, and aortic pulse wave velocity were measured in vivo. Thoracic aorta rings were studied ex vi
SUBMITTER: De Moudt S
PROVIDER: S-EPMC9483617 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA